Position papers are an essential tool for rare disease patient advocacy at EU level. They express the viewpoint of rare disease patients as a whole and are disseminated to regulatory authorities to influence decisions to be made, in the interest of patients.
Eurordis' position papers are adopted by the Eurordis Public Affairs Committee. Position papers are the official voice of a group of people and, as a consequence, seek consensus. In the absence of a consensus, they express the viewpoint of the majority of the group. It does not mean that every person belonging to the group agrees with the position expressed. Eurordis represents European rare disease patients at large. It is therefore important that minority views have the opportunity to be heard. This can happen during the drafting of a position paper; in such cases, the Eurordis Board of Directors is the ultimate decision maker. Minority views are recorded in Eurordis' public forums and discussions.
Position papers can be published at various moments in time: when an issue needs a special focus or is controversial; when European authorities launch a public consultation; when a future policy, programme, directive, or regulation is being drafted; or when Eurordis' members have a pressing issue to bring to the attention of EU decision makers and stakeholders concerned by the issue.
Flow-chart image. Please allow time for download. Text version is below.

Text version of the process for writing a Eurordis position paper:
Phase 1: First steps
Phase 2: Incorporate feedback-- three possible paths
Sometimes:
If there are no divergent opinions
If there are divergent opinions
Phase 3: Finalise position paper
Author: Eurordis
Graphics: © Eurordis